Atlas Trials

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

Clinical trial NCT02635243 · WITHDRAWN

Trial details

NCT number
NCT02635243
Sponsor
Sanofi
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2016-04-01
Primary completion
2016-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.